Marcus had been doing everything right for two years. Lifted four days a week, slept eight hours, ate clean protein, kept his body fat around fourteen percent. His testosterone came back at 620 ng/dL — solidly in the normal range. His doctor said he was fine. Marcus felt anything but fine. Low libido, difficulty building muscle despite consistent training, brain fog that rolled in every afternoon like a coastal storm.
He’d read enough to know total testosterone was only part of the story. What nobody had explained yet was the molecule quietly strangling his hormonal function: sex hormone binding globulin, or SHBG.
SHBG is one of the most consequential proteins in human physiology and one of the least discussed outside of endocrinology textbooks. A glycoprotein synthesized primarily in the liver, its sole job is to bind sex hormones — testosterone, dihydrotestosterone (DHT), and estradiol — and render them biologically inactive while they circulate in the bloodstream. Think of it as a hormone taxi that never drops off its passengers. Whatever SHBG carries doesn’t work. Just cargo moving through traffic.
When Marcus finally got a full panel that included SHBG, the number came back at 68 nmol/L. For context, the typical reference range sits between 10 and 57 nmol/L for adult men. His was elevated. Combined with his total testosterone of 620, that meant his calculated free testosterone — the fraction actually available to bind receptors and drive physiological effects — was around 8 pg/mL. Borderline low. Good total testosterone. Terrible hormonal function.
The SHBG was eating his results.
What SHBG Actually Does in the Body
Sex hormone binding globulin is a homodimeric protein — two identical subunits joined together — produced almost entirely by hepatocytes in the liver. Each monomer contains a steroid-binding domain that selectively grabs sex steroids with high affinity. The binding isn’t random. SHBG has a strong preference for DHT, binds testosterone with high affinity, and binds estradiol somewhat less tightly. When any of these hormones attach to SHBG, they can’t interact with androgen or estrogen receptors on target cells.
Neutralized.
Here’s the critical concept most doctors gloss over: only free testosterone and albumin-bound testosterone are biologically active. Free testosterone is exactly what it sounds like — floating unattached in the bloodstream, ready to diffuse into cells and bind nuclear receptors. Albumin-bound testosterone is loosely attached to albumin protein; because albumin binds hormones weakly, this fraction can easily detach and become active at tissue level. SHBG-bound testosterone, by contrast, stays bound.
It contributes to the total testosterone number on a lab report but delivers zero androgenic effect.
In a man with normal SHBG around 30 to 40 nmol/L, roughly 2 to 3 percent of circulating testosterone is free, another 44 to 65 percent is albumin-bound, and 35 to 54 percent is SHBG-bound. Shift SHBG up to 70 nmol/L and suddenly 70 to 75 percent of that testosterone is locked up. Free testosterone can drop by half even though the total hasn’t moved an inch.
Which is how a man with normal testosterone can experience every symptom of hypogonadism.
SHBG isn’t purely antagonistic, though. It has its own receptors on certain cell types — megakaryocytes, prostate epithelium, breast tissue — and can signal directly through what researchers call the SHBG receptor pathway. This pathway, described in work by Geoffrey Hammond’s laboratory at UBC, appears to modulate cellular responses independently of steroid binding. SHBG is both a hormone transport protein and, in some contexts, a signaling molecule in its own right.
The biology is messier and more interesting than “SHBG bad.”
The Liver Connection: Why SHBG Is Really a Metabolic Marker
Here’s the insight that reframes everything: SHBG is produced by the liver, and the liver’s metabolic state powerfully regulates how much SHBG it makes. Not a side note. The central organizing principle for understanding why SHBG varies so dramatically between individuals and what can actually be done about it.
The 2010 study by Ding et al. published in Human Molecular Genetics identified a promoter variant in the SHBG gene (rs1799941) strongly associated with circulating SHBG levels. Genetics explain only part of the variance, though. The rest is metabolic. Insulin is the most potent acute regulator of SHBG production. When pancreatic beta cells secrete insulin in response to carbohydrate intake, insulin signals the liver to reduce SHBG synthesis.
The mechanism involves insulin suppression of hepatocyte nuclear factor 4-alpha (HNF-4a), a transcription factor that directly drives SHBG gene expression.
This relationship has been replicated repeatedly. A landmark study in the Journal of Clinical Endocrinology and Metabolism by Wallace et al. (2013) found insulin resistance was the strongest predictor of low SHBG in a cohort of over 1,400 men and women. Higher fasting insulin meant lower SHBG, almost mechanistically.
Conversely, men with elevated SHBG tend to be insulin sensitive, often bordering on metabolically lean but sometimes excessively so — as with endurance athletes who’ve metabolized their way to very low body fat and elevated thyroid activity.
Non-alcoholic fatty liver disease (NAFLD) creates a particular paradox. Early NAFLD with insulin resistance crushes SHBG. But advanced liver fibrosis can eventually impair SHBG synthesis altogether while also impairing other liver functions, creating a more complex picture. For most people dealing with metabolic dysfunction rather than structural liver disease, insulin is the dial that matters most.
Which means SHBG is less a testosterone problem and more a metabolic health readout. Low SHBG often signals insulin resistance, obesity, and the hormonal environment that comes with poor metabolic health — typically combined with elevated estrogen and suppressed testosterone. High SHBG often signals either excessive leanness, hyperthyroidism, liver inflammation from non-metabolic causes, or genetic predisposition. Reading SHBG correctly means reading it in the context of everything else going on metabolically.
Causes of Elevated SHBG: The Full Clinical Picture
Not every elevated SHBG is the same. The causes span a wide range, and treating them without understanding the underlying driver produces unpredictable results. Worth being systematic about this.
Hyperthyroidism and subclinical thyroid excess. Thyroid hormones — particularly T3 (triiodothyronine) — directly stimulate hepatic SHBG production through thyroid response elements in the SHBG gene promoter. Men and women with elevated free T3, whether from Graves disease, subacute thyroiditis, or excessive thyroid hormone supplementation, routinely show SHBG levels above the normal range. A study in Thyroid (2014) found SHBG elevated in 68 percent of hyperthyroid patients and normalized following treatment.
Anyone using thyroid medication should note: even slightly supraphysiological T3 dosing pushes SHBG up significantly.
Liver inflammation and hepatitis. The paradox here is important: while metabolic liver disease (fatty liver) tends to suppress SHBG through insulin resistance, inflammatory liver conditions — viral hepatitis, autoimmune hepatitis, primary biliary cholangitis — can dramatically increase SHBG. The mechanism appears related to inflammatory cytokines altering hepatic protein synthesis in ways that paradoxically increase SHBG even as other liver functions are compromised.
Aging. SHBG rises with age in men at roughly 1 to 2 percent per year after age 40. A comprehensive analysis of the Massachusetts Male Aging Study found SHBG increasing from a median of around 35 nmol/L in men aged 40 to 49 to over 50 nmol/L in men over 70. This age-related increase explains why older men can have declining free testosterone even when total testosterone is maintained.
The pituitary-gonadal axis partially compensates by ramping up LH and testosterone production, but SHBG’s rise often outpaces compensation.
Extreme caloric restriction and eating disorders. Severe caloric deficit dramatically increases SHBG. This appears to be a survival adaptation — by binding and sequestering sex hormones during famine conditions, the body down-regulates reproductive investment. Studies in anorexia nervosa patients have shown SHBG values two to three times normal ranges. Elite athletes in caloric deficit — particularly endurance athletes in competitive season — often show similarly elevated SHBG.
Alcohol consumption patterns. Moderate-to-heavy alcohol use stimulates hepatic SHBG synthesis through mechanisms distinct from insulin pathways. A study in the European Journal of Clinical Nutrition found men consuming more than 20g of alcohol daily had significantly higher SHBG than abstainers, independent of body weight and insulin sensitivity. The combination of alcohol’s estrogenic effects (it promotes aromatization) with its SHBG-elevating effect creates a hormonal double bind for heavy drinkers.
Genetics. The rs1799941 polymorphism in the SHBG gene promoter creates a functional variant that alters transcription factor binding and increases SHBG production. Approximately 10 to 15 percent of the population carries alleles associated with chronically elevated SHBG regardless of lifestyle. High SHBG despite excellent metabolic health, appropriate caloric intake, and no thyroid issues points to genetics as the likely primary driver.
Causes of Low SHBG: The Metabolic Crisis Signal
The primary driver of low SHBG is hyperinsulinemia — chronically elevated insulin due to insulin resistance and excessive refined carbohydrate intake. High insulin directly suppresses the HNF-4a transcription factor that drives SHBG gene expression in hepatocytes. Which is why SHBG has emerged as a predictive biomarker for type 2 diabetes risk that outperforms fasting glucose in some studies.
A major meta-analysis in JAMA Internal Medicine (2009) by Ding et al. found low SHBG predicted type 2 diabetes development with an odds ratio of 1.80 per standard deviation decrease — a stronger prediction than many traditional risk factors.
In women, low SHBG combined with obesity and insulin resistance creates the hormonal substrate for polycystic ovary syndrome (PCOS). When SHBG falls, free testosterone and free DHT rise. In women, even small elevations in free androgens can disrupt follicular development, drive anovulation, and create the androgen excess symptoms — hirsutism, acne, irregular cycles — that characterize PCOS.
A 2019 review in Frontiers in Endocrinology described low SHBG as both a diagnostic marker and a likely pathophysiological factor in PCOS, not merely a downstream consequence.
Obesity itself directly suppresses SHBG through multiple mechanisms: increased insulin secretion, increased adipose-derived estrogens (aromatase activity), and potentially direct fatty liver effects on hepatic protein synthesis. Men with severe obesity often have total testosterone in the low-normal range and low SHBG, meaning free testosterone is actually relatively preserved — but the hormonal environment is chaotic, with elevated estradiol, leptin resistance, and inflammation complicating the picture.
Hypothyroidism suppresses SHBG through the opposite mechanism from hyperthyroidism — reduced thyroid hormone signaling through hepatic thyroid response elements reduces SHBG synthesis. Men and women with untreated or undertreated hypothyroidism frequently show low SHBG alongside their other symptoms.
Androgenic anabolic steroid use — exogenous testosterone or synthetic androgens — crushes SHBG, often to single-digit values. Which is why testosterone replacement therapy patients have disproportionately high free testosterone relative to total. But the suppression of SHBG in this context also increases free estradiol, complicating estrogen management significantly.
How to Actually Measure SHBG: Getting Useful Numbers
The measurement itself is straightforward — a standard blood draw, no special collection requirements — but interpreting it requires context, and the timing and accompanying tests matter enormously.
SHBG should always be measured alongside total testosterone and estradiol (at minimum) to allow calculation of free testosterone. The gold-standard method for measuring free testosterone is equilibrium dialysis, but this is expensive and rarely available outside research settings. The next best option is calculated free testosterone using the Vermeulen equation, which uses total testosterone, SHBG, and albumin to estimate free testosterone with reasonable accuracy. Online calculators from the Endocrine Society or ISSAM make this easy.
Many labs report a direct free testosterone measurement using a radioimmunoassay analog method — this method has been shown repeatedly to be inaccurate and should be ignored. Always use calculated free testosterone if equilibrium dialysis isn’t available.
For men, the test should be drawn in the morning, between 7 and 10 AM, in a fasted state. SHBG itself doesn’t fluctuate dramatically with time of day, but total testosterone does — it peaks in the morning and declines through the afternoon, sometimes by 30 to 40 percent. Drawing in the afternoon gives artificially low total testosterone, which then calculates to artificially low free testosterone, creating a picture of deficiency that may not be real.
This timing issue trips up more diagnostic workups than almost anything else.
Additional tests to order alongside SHBG: fasting insulin (reveals the insulin resistance context), free T3 and free T4 (thyroid’s effect on SHBG), estradiol (particularly in men, where elevated estradiol can indicate aromatase excess from obesity or alcohol), LH and FSH (to distinguish primary from secondary hypogonadism), and a basic metabolic panel to assess liver and kidney function. SHBG is a window-into-the-body protein; it tells more when read alongside the full metabolic story.
Reference ranges vary by laboratory and by age. In adult men, most labs use 10 to 57 nmol/L as the reference range, but this is a population-derived range, not a functional optimum. A 2020 study in the Journal of Clinical Endocrinology and Metabolism found men with SHBG below 25 nmol/L had significantly higher rates of metabolic syndrome and cardiovascular risk even when total testosterone was normal.
Optimal from a functional standpoint is probably 25 to 50 nmol/L for men, though this isn’t formalized in any guideline.
Dietary Strategies That Move SHBG
Diet is the most actionable lever for SHBG modulation, and the evidence is reasonably strong. The mechanisms connect directly to what’s known about insulin, liver function, and sex hormone metabolism.
Reducing refined carbohydrates and hyperinsulinemia. If low SHBG is driven by insulin resistance, reducing the glycemic load of the diet is the most direct intervention. A randomized trial by Hamalainen et al. published in Life Sciences (1984) remains a foundational study: men on a low-fat, high-fiber diet showed significant increases in SHBG and decreases in free testosterone compared to their baseline. While this study was examining cardiovascular diet effects, it demonstrated the diet-SHBG connection clearly.
More recent work on low-carbohydrate diets in insulin-resistant populations has shown SHBG increasing as fasting insulin drops — sometimes within eight to twelve weeks of dietary change.
Magnesium. Magnesium competes with testosterone for SHBG binding sites. A study by Excoffon et al. (2009) in Magnesium Research found oral magnesium supplementation increased free testosterone through a competitive binding mechanism — magnesium occupies some SHBG binding sites, displacing testosterone and increasing the free fraction. This doesn’t change total SHBG levels, but functionally increases testosterone bioavailability.
Doses of 400 to 500mg elemental magnesium daily appear effective; glycinate and malate forms have better bioavailability and fewer GI side effects than oxide.
Boron. Boron is a trace mineral that appears to suppress SHBG synthesis. A study by Naghii et al. (2011) in the Journal of Trace Elements in Medicine and Biology found 10mg per day of boron for one week reduced SHBG by approximately 9 percent while increasing free testosterone by 28 percent and free estradiol by 14 percent. The mechanism isn’t fully established, but may involve modulation of inflammatory pathways or direct effects on hepatic steroid hormone metabolism.
Boron is found naturally in raisins, almonds, avocados, and prunes; supplemental doses of 3 to 10mg are used in functional medicine contexts.
Dietary fat and cholesterol. Extremely low-fat diets consistently reduce testosterone and alter SHBG. Testosterone is synthesized from cholesterol, and dietary fat is a substrate for steroidogenesis. A meta-analysis in the European Journal of Clinical Nutrition (2021) found low-fat diets reduced total testosterone by an average of 10 to 15 percent compared to higher-fat diets.
The relationship with SHBG is complex — lower fat diets often increase SHBG in some studies, potentially through altered hepatic lipid metabolism — but the practical takeaway is that very low-fat eating generally impairs the hormonal environment for sex hormone activity.
Fiber and plant compounds. High dietary fiber intake is associated with increased SHBG in multiple observational studies. The mechanism likely involves fiber’s effects on gut microbiome composition, which in turn influences enterohepatic recirculation of sex hormones. Cruciferous vegetables contain indole-3-carbinol and diindolylmethane (DIM), which influence estrogen metabolism and may modestly affect SHBG through indirect pathways. These are mild effects rather than major interventions, but they contribute to the overall hormonal picture.
Exercise, Sleep, and Lifestyle Inputs
Resistance training. Heavy compound resistance training improves insulin sensitivity, increases androgen receptor density in muscle, and acutely elevates testosterone. Several studies have shown regular resistance training reduces SHBG in previously sedentary individuals, with one study in older men showing an 18 percent reduction in SHBG over 16 weeks of progressive strength training (Hakkinen et al., 2001). The mechanism is primarily through improved insulin sensitivity reducing hepatic SHBG synthesis.
The acute testosterone spike post-exercise is real but transient; the longer-term SHBG reduction from improved insulin sensitivity matters more.
Sleep quality and duration. Sleep is when most testosterone production occurs — LH pulses that drive Leydig cell testosterone synthesis are strongly coupled to sleep architecture, particularly slow-wave sleep. Sleep restriction to five hours per night has been shown to reduce testosterone by 10 to 15 percent within one week (Leproult and Van Cauter, 2011, JAMA).
The relationship with SHBG is less directly studied, but the insulin resistance that accumulates with chronic sleep restriction would predict upward pressure on SHBG in already insulin-resistant individuals. Sleep is not optional hormone optimization.
Body fat management. Adipose tissue is endocrinologically active. Aromatase enzyme in fat cells converts testosterone to estradiol; elevated estradiol then signals the hypothalamic-pituitary axis to reduce LH secretion, lowering testosterone production. Simultaneously, the insulin resistance accompanying obesity suppresses SHBG. Losing body fat — particularly visceral fat — often produces simultaneous improvements: lower insulin, higher SHBG (if low SHBG was the problem), and in men, lower aromatase activity allowing testosterone to recover.
Even modest fat loss of 10 to 15 percent of body weight can produce clinically meaningful hormonal changes.
Stress and cortisol. Chronic psychological stress maintains elevated cortisol, which competes with testosterone for receptor binding and suppresses gonadotropin-releasing hormone (GnRH) pulsatility. Cortisol doesn’t directly modulate SHBG in a well-established way, but the cortisol-testosterone antagonism is real and clinically meaningful. Additionally, the hyperinsulinemia that often accompanies chronic stress — through cortisol’s effects on insulin sensitivity — will secondarily affect SHBG in susceptible individuals.
Alcohol reduction. Given alcohol’s independent SHBG-elevating effect beyond its caloric contribution to insulin resistance, reducing alcohol is one of the more impactful lifestyle interventions for men with elevated SHBG who are otherwise metabolically healthy. Even reducing from moderate-heavy to light-moderate consumption shows SHBG changes within four to eight weeks in clinical observation.
Medical Interventions for Abnormal SHBG
Lifestyle modification addresses the underlying metabolic causes of SHBG dysregulation in most cases. But there are situations where pharmacological intervention is appropriate — particularly for men with symptomatic hypogonadism driven by elevated SHBG despite optimized lifestyle.
Testosterone replacement therapy (TRT). Exogenous testosterone dramatically suppresses SHBG — often by 40 to 60 percent — while simultaneously increasing total testosterone. The net effect is a large increase in free testosterone. Which is why TRT is effective for men with low free testosterone even when total testosterone is in the normal range. The standard protocols — testosterone cypionate or enanthate injections every one to two weeks, or daily topical gels — produce different SHBG suppression patterns.
Injections create higher peak testosterone levels that more strongly suppress SHBG; daily gels create steadier suppression. The decision to start TRT requires thorough workup, ruling out reversible causes of hormonal dysfunction first.
Anastrozole and aromatase inhibitors. In men with elevated SHBG combined with elevated estradiol (typically obese men or heavy drinkers), aromatase inhibitors like anastrozole can reduce estradiol conversion, which in turn reduces hepatic SHBG stimulation by estrogens. However, estradiol is essential for bone health, libido, and cardiovascular function in men; over-suppressing it creates new problems. Aromatase inhibitors should be used only when estradiol is genuinely elevated and causing problems, not prophylactically.
Danazol and synthetic androgens. Danazol is a synthetic androgen that potently suppresses SHBG — it’s sometimes used in women with endometriosis or hereditary angioedema. Not a first-line option for SHBG management in healthy individuals given its androgenic side effects, but it illustrates that synthetic androgens can be targeted for SHBG suppression in specific clinical contexts.
Thyroid optimization. For men with elevated SHBG driven by hyperthyroidism or excessive thyroid hormone supplementation, the intervention is thyroid-specific: treat the underlying thyroid condition. Reducing T4/T3 levels to within normal range typically normalizes SHBG within two to three months.
Metformin. In insulin-resistant individuals — particularly women with PCOS — metformin improves insulin sensitivity and can significantly increase SHBG as insulin levels fall. A Cochrane review on metformin in PCOS found consistent SHBG increases accompanying insulin improvements across multiple trials. Metformin isn’t a hormone drug, but its metabolic effects ripple through to SHBG meaningfully.
SHBG in Women: A Different Landscape
SHBG’s role in women’s health is equally important but underappreciated in the medical mainstream. Women have higher SHBG than men on average — typically 40 to 120 nmol/L in premenopausal women — because estrogens stimulate hepatic SHBG production. This is the physiological design: women have higher SHBG to prevent excess androgen activity, since free testosterone in women drives virilization at relatively low absolute concentrations.
Oral contraceptives dramatically increase SHBG. Ethinyl estradiol in combined OCP formulations is a potent SHBG stimulator — studies consistently show two to four-fold increases in SHBG with standard oral contraceptives. This has several consequences. First, it reduces free testosterone, which can impair libido. Second, it suppresses free androgens that some women rely on for energy, assertiveness, and muscle maintenance.
Third — and this is a critical clinical finding — SHBG elevations from OCPs can persist for months to years after discontinuation. A study by Panzer et al. (2006) in the Journal of Sexual Medicine found women who had taken OCPs had persistently elevated SHBG and lower free testosterone compared to never-users even after stopping, potentially related to epigenetic changes in hepatic SHBG regulation.
Perimenopause and menopause create a different SHBG story. As estradiol declines in menopause, SHBG should theoretically decline as well. In practice, the age-related SHBG increase often partially offsets this, creating variable SHBG levels in postmenopausal women that complicate hormone therapy decisions. Postmenopausal women on oral estrogen therapy will see SHBG rise significantly; transdermal estrogen has much less effect on SHBG because it bypasses first-pass hepatic metabolism.
PCOS, as mentioned, creates chronically low SHBG through insulin resistance and is one of the key diagnostic and pathophysiological features of the syndrome. Normalizing SHBG — through lifestyle improvement or metformin — is an important treatment goal, not merely a byproduct of treatment.
SHBG as a Longevity and Disease Risk Marker
Cardiovascular disease. Multiple large prospective cohort studies have found that low SHBG predicts cardiovascular events in both men and women. The European Prospective Investigation into Cancer and Nutrition (EPIC) study found low SHBG associated with a 2.4-fold increased risk of type 2 diabetes and significantly higher cardiovascular risk. A meta-analysis in PLOS Medicine (2011) confirmed lower SHBG predicted coronary artery disease in women, independent of conventional risk factors.
Part of this is SHBG being a proxy for metabolic health — low SHBG reflects insulin resistance, which drives cardiovascular risk directly. But there may also be direct effects of sex hormone availability on vascular function, lipid metabolism, and inflammation.
Type 2 diabetes. The diabetes prediction data for SHBG is among the strongest in the literature. A genome-wide association study published in Nature Genetics (2010) found SHBG genetic variants associated with lower SHBG were associated with higher diabetes risk, using Mendelian randomization to argue for causality rather than mere correlation. If SHBG genetically determined to be low increases diabetes risk, then SHBG itself (or the hormonal environment it creates) participates in metabolic disease pathogenesis.
Bone health. SHBG affects bone remodeling through its effects on free estradiol and testosterone, both essential for maintaining bone mineral density. Men with very high SHBG — particularly elderly men with age-related SHBG elevation — often have lower free estradiol, which is the primary driver of bone maintenance in aging men (counterintuitive as that sounds). Low free estradiol in men with high SHBG drives osteoporosis risk.
Which is why estradiol management in hypogonadal men on TRT is as important as testosterone levels — overly suppressing estradiol with aromatase inhibitors can paradoxically accelerate bone loss.
Cognitive function. Emerging research suggests sex hormones modulate neuroplasticity, synaptic density, and neuroinflammation. SHBG’s role in regulating free testosterone and estradiol availability to the brain makes it potentially relevant to cognitive aging. A study in the Journal of Alzheimer’s Disease (2019) found lower free testosterone (driven in part by higher SHBG) was associated with faster cognitive decline in older men. Whether SHBG-targeted interventions can preserve cognitive function remains an open research question.
Putting It All Together: An Optimization Framework
Understanding SHBG gives a coherent framework for hormonal optimization that goes beyond the simplistic “raise testosterone” approach. The framework looks like this: SHBG is the gatekeeper of sex hormone bioavailability. It responds to insulin sensitivity, thyroid status, body composition, liver health, age, and genetics. Moving it in the right direction requires addressing the underlying metabolic and lifestyle drivers, not just chasing numbers.
For men with elevated SHBG and low free testosterone despite normal total testosterone, the diagnostic priorities are: rule out hyperthyroidism or over-supplemented thyroid, assess alcohol intake, evaluate for significant caloric restriction, check genetics if all else is negative, and consider age-related rise if over 50. Interventions: optimize thyroid, reduce alcohol, ensure adequate caloric intake, consider boron and magnesium supplementation, and if lifestyle optimization is insufficient and symptoms are significant, discuss TRT with an endocrinologist.
For men with low SHBG combined with metabolic syndrome features, the approach is primarily metabolic: reduce refined carbohydrates, address insulin resistance through diet and exercise, lose excess body fat, optimize sleep. As insulin sensitivity improves, SHBG will rise, free testosterone will normalize relative to total, and the hormonal environment will shift toward health. Often more effective than hormone therapy because it addresses root causes.
For women, oral contraceptive effects on SHBG are worth serious consideration — particularly for women experiencing sexual dysfunction or persistent low libido while on OCPs. Transitioning to non-hormonal or progestin-only contraception may improve SHBG dynamics and libido, though SHBG normalization may take months. PCOS management centers on insulin sensitization, which is simultaneously the metabolic and hormonal treatment.
Marcus, returning to where this started, made two changes. He cut his alcohol from four drinks a week to one, and addressed what turned out to be mildly elevated free T3 levels from overzealous supplementation with a T3-containing thyroid product. Over eight weeks, his SHBG dropped from 68 to 47 nmol/L. His calculated free testosterone moved from 8 to 13 pg/mL. He didn’t feel dramatically different overnight — hormonal changes are slow.
But three months later, the afternoon brain fog was gone, his training was producing results again, and his libido had returned to baseline. He hadn’t changed his testosterone. He’d just started understanding what had been getting in its way.
What People Ask About SHBG Actually Does About SHBG
Q: My total testosterone is normal but I have low T symptoms. Should I test SHBG?
Absolutely. Normal total testosterone with symptoms of low testosterone — fatigue, low libido, poor recovery, brain fog — makes testing SHBG to calculate free testosterone one of the most important next steps. Normal total testosterone with high SHBG is a well-recognized clinical entity that causes genuine hypogonadal symptoms and responds to treatment. Any testosterone panel without SHBG is incomplete for diagnostic purposes.
Q: Can I raise SHBG naturally if it’s too low?
Yes, primarily through improving insulin sensitivity. Reducing refined carbohydrates, increasing physical activity, losing excess body fat, and improving sleep are the most effective strategies. Fasting — particularly intermittent fasting protocols that reduce total insulin exposure — has also been shown to increase SHBG in some studies through reduced insulin signaling. Correcting hypothyroidism will raise SHBG if that was the driver. The timeline is typically eight to sixteen weeks to see meaningful change.
Q: Does fasting testosterone testing time really matter that much?
More than most people realize. Total testosterone has a diurnal variation of 30 to 40 percent in men, with morning peaks and afternoon troughs. Testing at 3 PM versus 8 AM can make the difference between a normal and low result. Which is why guidelines from the Endocrine Society specify morning testing. Non-fasting can also affect results because a large meal triggers insulin, which acutely modulates hormone-binding protein dynamics. For any testosterone-related workup, morning fasting is the standard.
Q: I’m a woman on birth control and my libido is low. Could SHBG be involved?
It’s a significant possibility. Oral combined contraceptives containing ethinyl estradiol typically increase SHBG two to four-fold, substantially reducing free testosterone. Since women’s libido is partly androgen-dependent, this SHBG-driven reduction in free testosterone can impair sexual desire even when total testosterone is normal. Additionally, the increased SHBG may reduce free estradiol as well, affecting vaginal lubrication and arousal.
Discussing contraceptive alternatives with lower SHBG impact — progestin-only pills, hormonal IUDs, barrier methods — is a reasonable step if libido impairment is significant.
Q: What’s the difference between SHBG and free testosterone on a standard lab panel?
Standard lab panels typically report total testosterone only. SHBG requires a separate add-on test. Direct free testosterone reported by some labs uses an analog assay method that is notoriously inaccurate and should be disregarded. For meaningful free testosterone data, request both total testosterone and SHBG together, then use the Vermeulen calculator with the albumin level (usually 4.3 g/dL if not measured) to calculate free testosterone.
This calculated value is far more accurate than direct free testosterone measurement from standard labs.
Q: Is there a connection between SHBG and prostate cancer risk?
The relationship is complex and counterintuitive. Low SHBG doesn’t straightforwardly increase prostate cancer risk. The saturation model proposed by Stacy Loeb and Abraham Morgentaler suggests prostate androgen receptors become saturated at relatively low testosterone concentrations, meaning increases in free testosterone above physiological levels don’t proportionally increase prostate cancer risk. Large epidemiological studies have generally found no increased prostate cancer risk with TRT in appropriate candidates.
However, men with personal or family history of prostate cancer should discuss hormone therapy decisions with a urologist or oncologist familiar with the current evidence.
Sex hormone binding globulin is not your enemy. It’s a readout. High SHBG is the liver telling you something about thyroid function, alcohol load, or caloric state. Low SHBG is the liver telling you something about insulin resistance and metabolic health. Learn to read the message instead of resenting the messenger.
The deeper lesson from SHBG applies broadly to hormonal health: the number that matters isn’t always the number that gets tested. Total testosterone is easy to order and easy to interpret in isolation. Free testosterone requires calculation and context. SHBG requires understanding the liver, insulin, thyroid, and body composition all at once. But that complexity is exactly why it’s so valuable — it forces a systems-level view of health rather than a single-variable fix.
And systems-level problems, more often than not, have systems-level solutions.
References
- Research on Discipline After (PubMed)
- NIA Brain Health
- MedlinePlus: Discipline After